Endoscopy 2012; 44(12): 1105-1113
DOI: 10.1055/s-0032-1310155
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett’s esophagus

H. Neuhaus
¹   Department of Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany
,
G. Terheggen
¹   Department of Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany
,
E. M. Rutz
¹   Department of Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany
,
M. Vieth
²   Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
,
B. Schumacher
¹   Department of Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

submitted 23 December 2011

accepted after revision 27 June 2012

Publication Date:
11 September 2012 (online)

Background and study aims: Endoscopic submucosal dissection (ESD) of early gastrointestinal tumors has been shown to achieve complete resection rates superior to endoscopic mucosal resection (EMR), but at the cost of higher risk. The aim of this study was to prospectively assess the feasibility and oncological results of ESD in patients with neoplastic Barrett’s esophagus in conjunction with subsequent radiofrequency ablation (RFA).

Methods: Patients with Barrett’s esophagus who had visible lesions containing high grade intraepithelial neoplasia (HGIN) or mucosal adenocarcinoma (MAC) up to 3 cm in diameter were included in the study. ESD was performed using a new waterjet-assisted system (WESD) with a HybridKnife (Erbe Elektromedizin GmbH, Tübingen, Germany). Primary outcome was the rate of complete tumor resection. RFA of residual intestinal metaplasia was offered to all patients with at least two negative follow-up endoscopies.

Results: Of 30 patients (m:f = 21:9; median age 60 years) with biopsy-proven MAC (n = 24) or HGIN (n = 6) with a median diameter of 2 cm, complete resection of the targeted area was achieved in 29 patients (96.7 %; 95 % confidence interval [CI] 82 % – 99 %); en bloc resection was achieved in 27 of these patients (90.0 %; 95 %CI 74 % – 97 %). Minor delayed bleedings occurred in two patients. One patient died due to a sudden cardiac death 7 days after an uneventful WESD. Specimen histology (n = 29) revealed no neoplasia in 3 patients, HGIN in 2, MAC in 21, and submucosal cancer in 3; complete resection was histologically confirmed in only 10 of the 26 patients with HGIN or adenocarcinoma (38.5 %; 95 %CI 22 % – 57 %). However, endoscopic follow-up (median 17 months) showed complete remission of neoplasia in 27 /28 (96.4 %; 95 %CI 81 % – 99 %) patients who underwent successful WESD and were alive at 30 days. One patient underwent EMR of residual tumor. All Barrett’s tissue was eradicated by ESD alone in 15 cases and by additional RFA in 8 /10 cases (not done in three patients).

Conclusions: ESD of Barrett’s neoplasia is feasible and safe, but does not achieve sufficient R0 resection rates to warrant its recommended use over piecemeal EMR. In combination with RFA it can achieve complete eradication of neoplastic and non-neoplastic Barrett’s epithelium. The discrepancy between insufficient oncological resection and good medium-term results needs to be studied further.

 
  • References

  • 1 Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s Esophagus. Gastroenterology 2000; 118: 670-677
  • 2 Peters FP, Kara MA, Rosmolen WD et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc 2005; 61: 506-514
  • 3 Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinoma (Barrett’s cancer). Gastrointest Endosc 2007; 65: 3-10
  • 4 Pech O, Behrens A, May A et al. Long-term results and risk analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s esophagus. Gut 2008; 57: 1200-1206
  • 5 Fujishiro M, Yahagi N, Kakushima N et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 2006; 4: 688-694
  • 6 Gotoda T. Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol 2006; 22: 561-569
  • 7 Fujishiro M. Perspective of the practical indications of endoscopic submucosal dissection of gastrointestinal neoplasms. World J Gastroenterol 2008; 14: 4289-4295
  • 8 Saito Y, Uraoka T, Yamaguchi Y et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc 2010; 72: 1217-1225
  • 9 Cao Y, Liao C, Tan A et al. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 2009; 41: 751-757
  • 10 Neuhaus H, Costamagna G, Deviere J et al. Endoscopic submucosal resection (ESD) of early neoplastic gastric lesions using a new double channel endoscope (the “R-scope”). Endoscopy 2006; 38: 1016-1023
  • 11 Repici A, Hassan C, Carlino A et al. Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 2010; 71: 715-721
  • 12 Heresbach D, Kornhauser R, Seyrig JA et al. A national survey of endoscopic mucosal resection for superficial gastrointestinal neoplasia. Endoscopy 2010; 42: 806-813
  • 13 Ribeiro-Mourao F, Piemental-Nunes P, Dinis-Ribeiro M. Practice of endoscopic submucosal dissection by European gastroenterologists: we are still beginners!. Endoscopy 2010; 42: 814-819
  • 14 Probst A, Pommer B, Golger D et al. Endoscopic submucosal dissection in gastric neoplasia – experience from a European center. Endoscopy 2010; 42: 1037-1044
  • 15 Deprez PH, Bergman JJ, Meisner S et al. ESD in Europe: current practice and statements on clinical use. Endoscopy 2010; 42: 853-859
  • 16 Kaehler GFBA, Sold MG, Fischer K. Selective fluid cushion in the submucosal layer by water jet: advantage for endoscopic mucosal resection. Eur Surg Res 2007; 39: 93-97
  • 17 Kaehler GFBA, Colet PH, Sold MG et al. Waterjet for mucosal elevation in the GI tract – first clinical trial. Gastrointest Endosc 2007; 65: AB288
  • 18 Kaehler GFBA, Sold MG, Lingenfelder T et al. Needle knife and water jet combined as a hybrid knife – a comparison with standard knife in an in vivo animal study. Gastrointest Endosc 2007; 65: AB285
  • 19 Yahagi N, Neuhaus H, Schumacher B et al. Comparison of standard endoscopic submucosal dissection (ESD) versus an optimized ESD technique for colon: an animal study. Endoscopy 2009; 41: 340-345
  • 20 Schumacher B, Deinert K, Philipper M et al. Experimental testing of a new hybrid knife for endoscopic submucoal dissection (ESD) in the esophagus. Gastrointest Endosc 2007; 65: AB278
  • 21 Neuhaus H, Wirths K, Schenk M et al. Randomized controlled study of endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection with a waterjet hybridknife (ESDH) of esophageal lesions in a porcine model. Gastrointest Endosc 2009; 70: 112-120
  • 22 Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-578
  • 23 Riphaus A, Wehrmann T, Weber B et al. S3-guidelines sedation in gastrointestinal endoscopy. Z Gastroenterol 2008; 46: 1298-1330
  • 24 Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
  • 25 Vieth M, Stolte M. Pathology of early upper GI cancers. Best Pract Res Clin Gastroenterol 2005; 19: 857-869
  • 26 Pouw RE, Wirths K, Eisendraht P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010; 8: 23-29
  • 27 Manner H, May A, Pech O et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103: 2589-2597
  • 28 Alvarez Herrero L, Pouw RE, van Vilsteren FG et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 2011; 43: 177-183
  • 29 May A, Gossner L, Pech O et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2001; 14: 1085-1091
  • 30 Behrens A, May A, Gossner L et al. Curative treatment for high-grade intraepithelial neoplasia in Barrett’s esophagus. Endoscopy 2005; 37: 999-1005
  • 31 Yoshinaga S, Gotoda T, Kusano C et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 2008; 67: 202-209
  • 32 Ikeda K, Isomoto H, Oda H et al. Endoscopic submucosal dissection of a minute intramucosal adenocarcinoma in Barrett’s esophagus. Dig Endosc 2009; 21: 34-36
  • 33 Fukami N, Ryu CB, Said S et al. Prospective, randomized study of conventional versus HybridKnife endoscopic submucosal dissection methods for the esophagus: an animal study. Gastrointest Endosc 2011; 73: 1246-1253
  • 34 Barreton GB, Aust DE. Barrett’s esophagus: an update [article in German]. Pathologe 2012; 33: 5-16
  • 35 Saito Y, Uraoka T, Yamaguchi Y et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc 2010; 72: 1217-1225
  • 36 Sharma P, Meining AR, Coron E et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011; 74: 465-472
  • 37 Gaddam S, Mathur SC, Singh M et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett’s esophagus. Am J Gastroenterol 2011; 106: 1961-1969
  • 38 Deprez PH, Piessevaux H, Aouattah T et al. ESD in Barrett’s esophagus high grade dysplasia and mucosal cancer: prospective comparison with CAP mucosectomy. Gastrointest Endosc 2010; 71: AB126
  • 39 Van Vilsteren FGI, Pouw RE, Seewald S et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomized trial. Gut 2011; 60: 765-773